Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies-Reference-Cited by-同舟云学术

Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies

Published:2022-08 Issue:8 Volume:28 Page:1729-1731
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Nevejan Louis,Cuypers Lize,Laenen Lies,Van Loo Liselotte,Vermeulen François,Wollants Elke,Van Hecke Ignace,Desmet Stefanie,Lagrou Katrien,Maes Piet,André Emmanuel

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference8 articles.

1. Mullen JL, Tsueng G, Abdel Latif A, Alkuzweny M, Cano M, Haag E, Outbreak information. A standardized, open-source database of COVID-19 resources and epidemiology data [cited 2022 Feb 4]. https://outbreak.info

2. Duration of severe acute respiratory syndrome coronavirus 2 natural immunity and protection against the Delta variant: a retrospective cohort study.;Kim;Clin Infect Dis,2021

3. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.;Pulliam;Science,2022

4. European Centre for Disease Prevention and Control. Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA [cited 2022 Mar 21]. https://www.ecdc.europa.eu/en/publications-data/reinfection-sars-cov-2-implementation-surveillance-case-definition-within-eueea

5. European Commission. EU Digital COVID Certificate. 2022 [cited 2022 May 10]. https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid-19-vaccines-europeans/eu-digital-covid-certificate_en

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 reinfection rate before and after VOC Omicron emergence: a retrospective study in Brazil;Brazilian Journal of Microbiology;2024-07-25

2. Treatment of Acute COVID-19 and COVID-19 Exposures in Children and Adolescents;Pediatric Emergency Care;2024-03

3. Clinical course and management of COVID-19 in the era of widespread population immunity;Nature Reviews Microbiology;2023-12-19

4. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022;Emerging Infectious Diseases;2023-11

5. Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada;The Lancet Healthy Longevity;2023-08